Delivery Order SPE2DB24D8002-SPE2DB25FJNSE
Award Date
5/9/25
Potential Completion Date
5/12/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $7,091.73 to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. This contract, with a performance period ending on March 4, 2024, is for the delivery of Dupixent 300 mg/2 ml syringes. This award is part of a larger Indefinite Delivery Contract (IDC), identified as SPE2DB24D8001, which allows Dakota Drug, Inc. to provide a wide range of pharmaceutical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $13,666.77, is for the delivery of Dupixent 300 mg/2 ml syringes to support U.S. Armed Forces medical operations. The contract is a firm-fixed-price, unrestricted (no set-aside) contract with a performance period ending on April 29, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,542.59, is for the supply of Dupixent 300 mg/2 ml syringes. The award is part of DLA Troop Support Medical's ECAT Generation V Program, a broader Indefinite Delivery Contract (IDC) with Dakota Drug, Inc. valued at $999,999,999.00. The IDC allows the company to provide a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,867.25 firm-fixed-price contract is for the delivery of a pharmaceutical product, Dupixent 300 mg/2 ml syringe, with a completion date of December 6, 2023. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, specifically Dupixent 300 mg/2 ml syringes, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $3,734.50 and a performance period ending on April 28, 2025. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract has a ceiling value of $7,469.04 and a period of performance ending on September 17, 2024. Dakota Drug, Inc. is a prime contractor to the DLA Troop Support Medical, playing a crucial role in supporting the medical supply chain operations for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Dupixent 300 mg/2 ml syringes. The contract is a firm fixed-price delivery order with a ceiling value of $3,056.09 and a period of performance through February 12, 2025. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,274.15 firm fixed-price delivery order is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a period of performance through February 1, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, as part of the ECAT Generation V Program, which allows the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml syringe. The contract has a ceiling value of $29,253.41 and a period of performance through September 19, 2024. Dakota Drug, Inc. is an experienced federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Dupixent 300 mg/2 ml syringes, with a ceiling value of $3,826.50 and a performance period through December 13, 2024. The award is associated with Dakota Drug, Inc.'s existing Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, which has a ceiling value of...